Notice of the making of this Statutory Instrument was published in | ||
“Iris Oifigiúil” of 28th December, 2018. | ||
I, SIMON HARRIS, Minister for Health, in exercise of the powers conferred on me by sections 5 and 29 and by section 31 (amended by section 34 of the Health Act 1953 (No. 26 of 1953)) of the Health Act 1947 (No. 28 of 1947) hereby make the following regulations: | ||
1. These Regulations may be cited as the Infectious Diseases (Amendment) Regulations 2018. | ||
2. The Infectious Diseases Regulations 1981 ( S.I. No. 390 of 1981 ) are amended— | ||
(a) in Regulation 14, by the deletion of paragraph (2) (amended by Regulation 4 of the Infectious Diseases (Amendment) Regulations 2007 ( S.I. No. 559 of 2007 )), and | ||
(b) by the substitution of the following Schedule for the Schedule (amended by Regulation 2 of the Infectious Diseases (Amendment) Regulations 2016 ( S.I. No. 276 of 2016 )) to those Regulations: | ||
“SCHEDULE | ||
Diseases specified to be infectious diseases and their respective causative pathogens | ||
| ||
| ||
GIVEN under my Official Seal, | ||
18 December 2018. | ||
SIMON HARRIS, | ||
Minister for Health. | ||
EXPLANATORY NOTE | ||
(This note is not part of the Regulation and does not purport to be a legal interpretation) | ||
These Regulations amend Regulation 14 of the Infectious Diseases Regulations 1981 ( S.I. No. 390 of 1981 ) by the deletion of paragraph (2) (amended by Regulation 4 of the Infectious Diseases (Amendment) Regulations 2007 ( S.I. No. 559 of 2007 )), the effect of which is to require both confirmed or suspected cases of Creutzfeld Jakob disease and variant Creutzfeld Jakob disease which are diagnosed to be reported to the medical officer of health, in line with all other diseases listed on the Schedule to the Infectious Diseases Regulations 1981. | ||
These Regulations also amend the Schedule to the Infectious Diseases Regulations 1981 (as amended) to include Carbapenemase producing enterobacteriaceae, Herpes simplex (neonatal), mcr-positive Enterobacteriaceae, and Novel or Rare Antimicrobial-resistant Organisms as additional infectious diseases which are required to be notified. |